Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Vascular Endothelial Growth Factor B market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Vascular Endothelial Growth Factor Bmarket, defines the market attractiveness level of Vascular Endothelial Growth Factor B market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Vascular Endothelial Growth Factor B industry, describes the types of Vascular Endothelial Growth Factor B market, the applications of major players and the market size, and deeply analyzes the current situation of the global Vascular Endothelial Growth Factor B market and the development prospects and opportunities of Vascular Endothelial Growth Factor B industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Vascular Endothelial Growth Factor B market in Chapter 13.
By Player:
Formycon AG
Regeneron Pharmaceuticals Inc
Eli Lilly and Company
CSL Ltd
Alteogen Inc
By Type:
Aflibercept
Aflibercept Biosimilar
CSL-346
Others
By End-User:
Rectal Cancer
Retinal Vein Occlusion
Diabetic Nephropathy
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Vascular Endothelial Growth Factor B Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Vascular Endothelial Growth Factor B Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Vascular Endothelial Growth Factor B Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Vascular Endothelial Growth Factor B Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Vascular Endothelial Growth Factor B Market Analysis and Outlook to 2022
-
7.1 Global Vascular Endothelial Growth Factor B Consumption (2017-2022)
-
7.2 United States Vascular Endothelial Growth Factor B Consumption (2017-2022)
-
7.3 Europe Vascular Endothelial Growth Factor B Consumption (2017-2022)
-
7.4 China Vascular Endothelial Growth Factor B Consumption (2017-2022)
-
7.5 Japan Vascular Endothelial Growth Factor B Consumption (2017-2022)
-
7.6 India Vascular Endothelial Growth Factor B Consumption (2017-2022)
-
7.7 South Korea Vascular Endothelial Growth Factor B Consumption (2017-2022)
8 Region and Country-wise Vascular Endothelial Growth Factor B Market Analysis and Outlook to 2028
-
8.1 Global Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)
-
8.2 United States Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)
-
8.3 Europe Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)
-
8.4 China Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)
-
8.5 Japan Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)
-
8.6 India Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)
-
8.7 South Korea Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)
9 Global Vascular Endothelial Growth Factor B Market Outlook by Types and Applications to 2022
-
9.1 Global Vascular Endothelial Growth Factor B Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Aflibercept Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Aflibercept Biosimilar Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CSL-346 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Vascular Endothelial Growth Factor B Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Rectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retinal Vein Occlusion Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diabetic Nephropathy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Vascular Endothelial Growth Factor B Market Outlook by Types and Applications to 2028
-
10.1 Global Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Aflibercept Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Aflibercept Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CSL-346 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Rectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retinal Vein Occlusion Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diabetic Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Vascular Endothelial Growth Factor B Import and Export Analysis (Top 5 Countries)
-
11.1 Global Vascular Endothelial Growth Factor B Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Vascular Endothelial Growth Factor B Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Vascular Endothelial Growth Factor B Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Vascular Endothelial Growth Factor B Market Competitive Analysis
-
14.1 Formycon AG
-
14.1.1 Formycon AG Company Details
-
14.1.2 Formycon AG Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Formycon AG Vascular Endothelial Growth Factor B Product and Service
-
14.2 Regeneron Pharmaceuticals Inc
-
14.2.1 Regeneron Pharmaceuticals Inc Company Details
-
14.2.2 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product and Service
-
14.3 Eli Lilly and Company
-
14.3.1 Eli Lilly and Company Company Details
-
14.3.2 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Product and Service
-
14.4 CSL Ltd
-
14.4.1 CSL Ltd Company Details
-
14.4.2 CSL Ltd Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 CSL Ltd Vascular Endothelial Growth Factor B Product and Service
-
14.5 Alteogen Inc
-
14.5.1 Alteogen Inc Company Details
-
14.5.2 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Alteogen Inc Vascular Endothelial Growth Factor B Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Vascular Endothelial Growth Factor B
-
Figure Vascular Endothelial Growth Factor B Picture
-
Table Global Vascular Endothelial Growth Factor B Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Vascular Endothelial Growth Factor B Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Vascular Endothelial Growth Factor B Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Vascular Endothelial Growth Factor B Consumption by Country (2017-2022)
-
Figure United States Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)
-
Table Europe Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)
-
Figure China Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)
-
Figure Japan Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)
-
Figure India Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)
-
Figure South Korea Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)
-
Figure Global Vascular Endothelial Growth Factor B Consumption Forecast by Country (2022-2028)
-
Figure United States Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aflibercept Consumption and Growth Rate (2017-2022)
-
Figure Global Aflibercept Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Global CSL-346 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Rectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Retinal Vein Occlusion Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Nephropathy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Aflibercept Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aflibercept Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CSL-346 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retinal Vein Occlusion Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetic Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Vascular Endothelial Growth Factor B Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Vascular Endothelial Growth Factor B Export by Region (Top 5 Countries) (2017-2028)
-
Table Formycon AG (Foundation Year, Company Profile and etc.)
-
Table Formycon AG Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Formycon AG Vascular Endothelial Growth Factor B Product and Service
-
Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Vascular Endothelial Growth Factor B Product and Service
-
Table CSL Ltd (Foundation Year, Company Profile and etc.)
-
Table CSL Ltd Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Ltd Vascular Endothelial Growth Factor B Product and Service
-
Table Alteogen Inc (Foundation Year, Company Profile and etc.)
-
Table Alteogen Inc Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alteogen Inc Vascular Endothelial Growth Factor B Product and Service
-
